The reliability of HBV core antibody in serological screening for hepatitis B virus

Pathology

Volumn 45, Issue 5, 2013, Pages 501-505

  Ba Alawi, Fatma ^a   Robertson, Peter W ^a   Lepage, Amelia K ^a,b   Jayamaha, Jude ^a   Baleriola, Cristina ^a   Rawlinson, William D ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

HBcAb; HBsAg; HBV infection; HBV NAT; Organ donors

Indexed keywords

CORE PROTEIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD; CHILD; EVALUATION STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIRAL CORE PROTEINS; YOUNG ADULT;

EID: 84887981298     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283631cf9     Document Type: Article

References (36)

1. Pereira A, Jacobson I. Modern diagnosis of HBV infection. Curr Hepatitis Rep 2009; 8: 18-25.
2. Solves P, Mirabet V, Alvarez M, et al. Donors screening for hepatitis B virus infection in a cell and tissue bank. Transpl Infect Dis 2008; 10: 391-5.
3. The Transplantation Society of Australia and New Zealand. Organ Transplantation From Deceased Donors: Consensus Statement On Eligibility Criteria And Allocation Protocols. Version 1.1-23 June 2011. http://www.tsanz.com.au/downloads/201123June-TSANZConsensusStatementVs1.1.pdf
4. Challine D, Chevaliez S, Pawlotsky JM. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Gastroenterology 2008; 135: 1185-911.
5. Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donor: is the 'best' test the right test? A consensus conference report. Am J Transplant 2010; 10: 889-99.
6. Pruss A, Caspari G, Kruger DH, et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis 2010; 12: 375-86.
7. Fischer SA, Avery RK. AST Infectious Disease Community of Practice-Screening of donor and recipient prior to solid organ transplantation. Am J Transpl 2009; 9 (Suppl 4): S7-18.
8. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91: 1-12.
9. Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol 2005; 16: 65-72.
10. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, et al. Anti-HBc and HBVDNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 2006; 123: 37-42.
11. Zuckerman JN, Zukerman AJ. Mutations of the surface protein of hepatitis B virus. Antiviral Res 2003; 60: 75-8.
12. Louisirirotchanakul S, Khupulsup K, Akraekthalin S, et al. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym and Advia Centaur HBsAg screening assays. J Med Virol 2010; 82: 755-62.
13. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat 2010; 17: 1-15.
14. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-7.
15. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86: 83-91.
16. Jardi R, Rodriguiez F, Buti M, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and Hepatitis B precore and basal core and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34: 404-10.
17. Mimms LT, Mosley JW, Hollinger FB, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993; 307: 1095-7.
18. Baleriola C, Johal H, Robertson PR, et al. Infectious disease screening of blood specimens collected post-mortem provide comparable results to premortem specimens. Cell Tissue Bank 2011; 13: 251-8.
19. Hourfar MK, Walch LA, Geusendam G, et al. Sensitivity and specificity of Anti-HBc screening assays - which assay is best for blood donor screening. Int J Lab Hematol 2009; 31: 649-56.
20. Roth WK, Weber M, Petersen D, et al. NAT for HBVand anti-HBc testing increase blood safety. Transfusion 2002; 42: 869-75.
21. Baleriola C, Johal H, Jacka B, et al. Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -208°C and -708°C. J Clin Microbiol 2011; 49: 3163-7.
22. Baleriola C, Tu E, Johal H, et al. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time. Transplant Infect Dis 2012; 14: 278-87.
23. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from antihepatitis B core positive donors: a systematic review. J Hepatol 2010; 52: 272-9.
24. Levitsky J, Doucette K. AST Infectious Disease Community of Practice-Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S116-30.
25. Prakoso E, Strasser SI, Koorey DJ, et al. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface antigen negative liver transplant recipients from hepatitis B core antibody positive donors. Clin Transplant 2006; 20: 369-73.
26. Dhillon GS, Levitt J, Mallidi H, et al. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the united network for organ sharing database. Transplantation 2009; 88: 842-6.
27. Australia and New Zealand Organ Donation Registry, 2011. Cited September 2012. http://www.anzdata.org.au/anzod/v1/indexanzod.html
28. Seem DL, Lee I, Umscheid CA, Kuehnert MJ. Draft Public Health Service (PHS) Guideline for Reducing Transmission of HIV, HBV, and HCV through Solid Organ Transplantation. United States: Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
29. Dodd RY. Current safety of the blood supply in the United States. Int J Hematol 2004; 80: 301-5.
30. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplanation 1995; 59: 230-4.
31. Kuhns MC, Kleinman SH, McNamara AL, et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004; 44: 1332-9.
32. Alhababi F, Sallam TA, Tong CY. The significance of 'anti-HBc only' in the clinical virology laboratory. J Clin Virol 2003; 27: 162-9.
33. Grob C, Jilg W, Bornhak G, et al. Serological pattern'anti-HBc alone': report on a workshop. J Med Virol 2000; 62: 450-5.
34. Weinberger KM, Zoulek AR, Bauer T, et al. High genetic variability of the group-specific a determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 1999; 58: 105-10.
35. Gunther S, Fisher L, Puli I, et al. Naturally occurring varients of hepatitis B virus. Adv Virus Res 1999; 52: 25-137.
36. Seiskari T, Lehtisaari H, Haapala AM, et al. From Abbott ARCHITECT Anti-HBc to Anti-HBc II Improved performance in detecting antibodies to hepatitis B core antigen. J Clin Virol 2009; 47: 100-1.